Researcher

Chang Li

Yale University

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 26, 2026 · JOURNAL ARTICLE

Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.

International Journal of Pharmaceutics: X

A comprehensive review synthesizing current knowledge on biomaterial-based drug delivery for head and neck cancer, identifying clinical challenges and therapeutic opportunities without presenting original experimental data or clinical trial results.

Expert GuidanceJunxiong Wen Combination Therapy Xiao Cui

Reported

HNSCC and OSCC proportion of HNCapproximately 90%

5-year survival rate for advanced…50–60%

AUG 7, 2026 · JOURNAL ARTICLE

Spatial organisation of tumor-infiltrating B-cells informs immune checkpoint inhibitor response in Claudin 18.2-expressing gastric cancer

Clinical Cancer Research

Prospective profiling study identifying spatial B-cell organization as a potential biomarker for ICI response in CLDN18.2-expressing gastric cancer, with validation across five cohorts including a phase 3 trial, but lacking randomized comparison or prospective outcome prediction.

PromisingRaghav Sundar Joseph J. Zhao Choong‐kun Lee

Reported

Sample size (primary cohort)103

Cells profiled (multiplex immunoh…7,423,483

Regions of interest profiled2,315